What is TransMedics Group, Inc.'s revenue?

TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.

Is TransMedics Group, Inc. profitable?

TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.

What are TransMedics Group, Inc.'s profit margins?

Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.

What is TransMedics Group, Inc.'s earnings per share?

TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.

Where does TransMedics Group, Inc.'s income statement data come from?

Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

TransMedics Group, Inc. TMDX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$173.93M+8.2%	$160.76M+11.8%	$143.82M-8.6%	$157.37M+9.6%	$143.54M+18.0%
Total cost of revenue	$72.77M+8.1%	$67.35M+13.7%	$59.25M-2.5%	$60.78M+9.9%	$55.31M+11.5%
Gross profit	$101.16M+8.3%	$93.41M+10.5%	$84.58M-12.4%	$96.59M+9.5%	$88.23M+22.5%
Gross margin	58.2%+0.1pp	58.1%-0.7pp	58.8%-2.6pp	61.4%-0.1pp	61.5%+2.3pp
Research and development	$24.88M+20.2%	$20.7M+35.7%	$15.26M-4.2%	$15.93M-7.1%	$17.16M+4.2%
Selling, general and administrative	$62.99M+22.4%	$51.44M+11.8%	$46.02M+4.4%	$44.09M+1.1%	$43.63M-7.0%
Total operating expenses	$87.86M+21.8%	$72.14M+17.7%	$61.28M+2.1%	$60.02M-1.3%	$60.79M-4.1%
Operating income	$13.3M-37.5%	$21.27M-8.7%	$23.3M-36.3%	$36.57M+33.2%	$27.44M+217%
Operating margin	7.6%-5.6pp	13.2%-3.0pp	16.2%-7.0pp	23.2%+4.1pp	19.1%+12.0pp
Interest expense	$7.17M+114%	$3.35M-3.9%	$3.49M+0.4%	$3.48M+0.4%	$3.46M-3.1%
Other income (expense), net	-$4.81M—	——	-$269K+30.1%	-$385K+49.8%	-$767K+53.7%
Income before income taxes	$8.49M-60.8%	$21.63M-6.1%	$23.03M-36.3%	$36.18M+35.6%	$26.68M+282%
Income tax expense	$1.17M+101%	-$83.75M-6,402%	-$1.29M-201%	$1.28M+28.3%	$994K+653%
Net income	$7.32M-93.1%	$105.38M+333%	$24.32M-30.3%	$34.91M+35.9%	$25.68M+275%
Net margin	4.2%-61.3pp	65.6%+48.6pp	16.9%-5.3pp	22.2%+4.3pp	17.9%+12.3pp
Diluted earnings per share	$0.20-92.3%	$2.59+292%	$0.66-28.3%	$0.92+31.4%	$0.70+250%
EBITDA	$25.16M-12.5%	$28.74M-4.7%	$30.15M-30.4%	$43.3M+28.9%	$33.58M+134%
EBITDA margin	14.5%-3.4pp	17.9%-3.1pp	21%-6.6pp	27.5%+4.1pp	23.4%+11.6pp
EBIT	$13.3M-37.5%	$21.27M-8.7%	$23.3M-36.3%	$36.57M+33.2%	$27.44M+217%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about TransMedics Group, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TransMedics Group, Inc.'s revenue?: TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.
Is TransMedics Group, Inc. profitable?: TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.
What are TransMedics Group, Inc.'s profit margins?: Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.
What is TransMedics Group, Inc.'s earnings per share?: TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.
Where does TransMedics Group, Inc.'s income statement data come from?: Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.